» Articles » PMID: 29133485

Pyk2 and FAK Differentially Regulate Invadopodia Formation and Function in Breast Cancer Cells

Overview
Journal J Cell Biol
Specialty Cell Biology
Date 2017 Nov 15
PMID 29133485
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

The nonreceptor tyrosine kinase Pyk2 is highly expressed in invasive breast cancer, but the mechanism by which it potentiates tumor cell invasiveness is unclear at present. Using high-throughput protein array screening and bioinformatic analysis, we identified cortactin as a novel substrate and interactor of proline-rich tyrosine kinase 2 (Pyk2). Pyk2 colocalizes with cortactin to invadopodia of invasive breast cancer cells, where it mediates epidermal growth factor-induced cortactin tyrosine phosphorylation both directly and indirectly via Src-mediated Abl-related gene (Arg) activation, leading to actin polymerization in invadopodia, extracellular matrix degradation, and tumor cell invasion. Both Pyk2 and the closely related focal adhesion kinase (FAK) regulate tumor cell invasion, albeit via distinct mechanisms. Although Pyk2 regulates tumor cell invasion by controlling invadopodium-mediated functions, FAK controls invasiveness of tumor cells by regulating focal adhesion-mediated motility. Collectively, our findings identify Pyk2 as a unique mediator of invadopodium formation and function and also provide a novel insight into the mechanisms by which Pyk2 mediates tumor cell invasion.

Citing Articles

Calcium Channel Blocker Lacidipine Promotes Antitumor Immunity by Reprogramming Tryptophan Metabolism.

Sheng Y, Qiao C, Zhang Z, Shi X, Yang L, Xi R Adv Sci (Weinh). 2024; 12(3):e2409310.

PMID: 39585774 PMC: 11744582. DOI: 10.1002/advs.202409310.


Podosome Nucleation Is Facilitated by Multivalent Interactions between Syk and ITAM-containing Membrane Complexes.

Ghasempour S, Muise A, Freeman S J Immunol. 2024; 213(7):988-997.

PMID: 39140892 PMC: 11404668. DOI: 10.4049/jimmunol.2400031.


Focal adhesion kinase signaling - tumor vulnerabilities and clinical opportunities.

Schlaepfer D, Ojalill M, Stupack D J Cell Sci. 2024; 137(14).

PMID: 39034922 PMC: 11298715. DOI: 10.1242/jcs.261723.


Integrin αVβ1-activated PYK2 promotes the progression of non-small-cell lung cancer via the STAT3-VGF axis.

Wu Z, Jiao M, Shu C, Zhang S, Wang J, Pu J Cell Commun Signal. 2024; 22(1):313.

PMID: 38844957 PMC: 11157819. DOI: 10.1186/s12964-024-01639-1.


DAB2IP suppresses invadopodia formation through destabilizing ALK by interacting with USP10 in breast cancer.

Huang Q, Zhang R, Xia Y, Shen J, Dong H, Li X iScience. 2023; 26(9):107606.

PMID: 37664607 PMC: 10470318. DOI: 10.1016/j.isci.2023.107606.


References
1.
Litvak V, Tian D, Shaul Y, Lev S . Targeting of PYK2 to focal adhesions as a cellular mechanism for convergence between integrins and G protein-coupled receptor signaling cascades. J Biol Chem. 2000; 275(42):32736-46. DOI: 10.1074/jbc.M004200200. View

2.
Beaty B, Condeelis J . Digging a little deeper: the stages of invadopodium formation and maturation. Eur J Cell Biol. 2014; 93(10-12):438-44. PMC: 4262566. DOI: 10.1016/j.ejcb.2014.07.003. View

3.
Selitrennik M, Lev S . PYK2 integrates growth factor and cytokine receptors signaling and potentiates breast cancer invasion via a positive feedback loop. Oncotarget. 2015; 6(26):22214-26. PMC: 4673158. DOI: 10.18632/oncotarget.4257. View

4.
Wu H, Parsons J . Cortactin, an 80/85-kilodalton pp60src substrate, is a filamentous actin-binding protein enriched in the cell cortex. J Cell Biol. 1993; 120(6):1417-26. PMC: 2119758. DOI: 10.1083/jcb.120.6.1417. View

5.
Weaver A . Invadopodia: specialized cell structures for cancer invasion. Clin Exp Metastasis. 2006; 23(2):97-105. DOI: 10.1007/s10585-006-9014-1. View